Loading...
Images of Antoine Yver
(0 from 0 )News
UPDATE 1-AstraZeneca suffers setback as drug fails in eye cancer |...
www.reuters.com
* Selumetinib fails in Phase III trial for uveal melanoma* Drug continues to be tested in lung, other cancers* consensus sales forecast
FDA approves AstraZeneca's lung cancer drug Iressa - MarketWatch
www.marketwatch.com
... and patients in the U.S. with a new choice of first-line treatment for metastatic non-small cell lung cancer," Antoine Yver, AstraZeneca's head of oncology, ...
Daiichi Sankyo Announces Appointment of Antoine Yver World News
article.wn.com
EDISON, N.J., April 1, PRNewswire/ -- Daiichi Sankyo, Inc. today announced the appointment of Antoine Yver, MD, MSc, to Global Head, Oncology Research and Development, effective April 1, In this newly created role, Dr. Yver will report to Glenn Gormley, MD, PhD, Senior ...
AstraZeneca suffers setback as drug fails in eye cancer | Reuters
www.reuters.com
AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a...
sorted by relevance / date